About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Piroxicam
- Procedure number
- PSUSA/00002438/202004
- Regulatory outcome
- Variation
Documents
Piroxicam: List of nationally authorised medicinal products - PSUSA/00002438/202004
English (EN) (305.93 KB - PDF)
Piroxicam: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002438/202004
English (EN) (72.79 KB - PDF)
български (BG) (68.41 KB - PDF)
español (ES) (72.52 KB - PDF)
čeština (CS) (74.97 KB - PDF)
dansk (DA) (96.55 KB - PDF)
Deutsch (DE) (79.18 KB - PDF)
eesti keel (ET) (64.8 KB - PDF)
ελληνικά (EL) (66.38 KB - PDF)
français (FR) (73.61 KB - PDF)
hrvatski (HR) (80.07 KB - PDF)
íslenska (IS) (74.66 KB - PDF)
italiano (IT) (93.24 KB - PDF)
latviešu valoda (LV) (99.28 KB - PDF)
lietuvių kalba (LT) (80.26 KB - PDF)
magyar (HU) (74.01 KB - PDF)
Malti (MT) (100.18 KB - PDF)
Nederlands (NL) (74.68 KB - PDF)
norsk (NO) (70.97 KB - PDF)
polski (PL) (75.76 KB - PDF)
português (PT) (72.57 KB - PDF)
română (RO) (69.02 KB - PDF)
slovenčina (SK) (77 KB - PDF)
slovenščina (SL) (93.9 KB - PDF)
Suomi (FI) (70.58 KB - PDF)
svenska (SV) (71.17 KB - PDF)